Fructose Intolerance: Symptoms, Breath Test and What to Do After the Result

Fructose is a simple sugar (monosaccharide) found in fruit, honey, apple juice, glucose-fructose syrup and, as half of its mass, in ordinary table sugar (sucrose is glucose bound to fructose). In the small intestine fructose is absorbed mainly by the GLUT5 transporter on the surface of enterocytes and then passes into the blood via the GLUT2 transporter. GLUT5 works by facilitated diffusion and has limited capacity. Importantly, fructose given together with glucose is absorbed better, because glucose helps it cross the membrane. This is why the fructose-to-glucose ratio of a food matters in practice: sucrose (equal amounts of both sugars) is usually tolerated better than 'free' fructose in apple juice or honey.

The ability to absorb fructose is not the same in everyone and depends on dose. In a dose-response study of 20 healthy people (Rao et al., 2007) no one had a positive hydrogen test after 15 g of fructose, two people (10%) after 25 g but without symptoms, whereas after 50 g in a 10% solution as many as 16 people (80%) tested positive and 11 (55%) reported symptoms. The authors concluded that healthy people usually absorb up to about 25 g of fructose at once, and at larger doses malabsorption is more the rule than the exception. This matters for interpretation: demonstrating fructose malabsorption with a large test dose does not necessarily mean disease.

That is why it is best to think of fructose in terms of a tolerance threshold rather than all-or-nothing. One apple contains over ten grams of fructose (more in sweet varieties), a glass of apple juice similar or more, and then there is sorbitol (a polyol found in apples, pears, plums and 'sugar-free' sweets), which is poorly absorbed and itself worsens fructose absorption. The combination of fructose and sorbitol in one meal causes symptoms much more often than the same amount of fructose alone.

Unabsorbed fructose retains water in the bowel lumen (an osmotic effect) and reaches the large intestine, where bacteria ferment it into short-chain fatty acids and gases (hydrogen, carbon dioxide and, in some people, methane). Stretching of the bowel and extra fluid lead to bloating, pain, rumbling, flatulence and diarrhoea. It seems intuitive, then, that the worse someone absorbs fructose, the stronger the symptoms. The data are less simple.

What does this mean in practice? Symptoms after fructose arise from a combination of three elements: the amount of unabsorbed sugar, how the microbiota ferments it (how much gas it produces and which), and how strongly the gut reacts to stretching. In people with irritable bowel syndrome and other functional bowel disorders the last component, visceral hypersensitivity, is often key. This is why two people with identical breath-test results can have completely different complaints, and the same person can feel worse or better after the same meal depending on stress, sleep and cycle phase.

Typical symptoms of fructose malabsorption appear from 30 minutes to a few hours after a meal rich in fructose or sorbitol: bloating and a feeling of fullness, excessive gas, rumbling, abdominal pain or cramps, diarrhoea or loose stools, sometimes nausea. Complaints are usually linked to dose and meal context (juice on an empty stomach vs an apple after lunch), and between episodes the patient may feel well. The absence of night-time symptoms, weight loss, blood in the stool and anaemia points to a benign, functional background.

The symptoms are almost impossible to tell apart from diarrhoea-predominant irritable bowel syndrome, lactose intolerance, SIBO or reactions to other fermentable carbohydrates. This is no coincidence: the low-FODMAP diet (fermentable oligo-, di-, monosaccharides and polyols, which include excess fructose and sorbitol) was created precisely to limit this whole pool of substances. So if someone reacts to fructose but also to onion, garlic, legumes and milk, the conclusion 'it is just fructose' would be too simple.

The distribution of malabsorption in the population is also interesting. In the study by Barrett et al. (2009), which used the same breath-test protocol in patients with Crohn's disease, ulcerative colitis, functional bowel disorders, coeliac disease and in healthy volunteers, fructose malabsorption was more frequent in Crohn's disease (61%), while in the other groups, including healthy people, it occurred in 33-44%. This means a positive fructose breath test is a very common finding even without symptoms, and the authors summed up that carbohydrate malabsorption can be a normal physiological phenomenon. A test result without symptoms, or without a link between symptoms and the test dose, is therefore not enough to diagnose 'intolerance'.

Hereditary fructose intolerance (HFI) is a different matter from the malabsorption described above. It is an autosomal recessive metabolic disease caused by mutations of the ALDOB gene, which encodes aldolase B, a liver enzyme that metabolises fructose-1-phosphate. After intake of fructose, sucrose or sorbitol, fructose-1-phosphate accumulates in the liver, kidneys and intestine, blocks glucose release and leads to hypoglycaemia, lactic acidosis, hypophosphataemia, hyperuricaemia and liver and kidney damage. According to estimates from a Central European population study (Santer et al., 2005), the frequency of HFI is about 1 in 26,100 people (95% CI 1:12,600-79,000), and the most common mutations are p.A150P, p.A175D and p.N335K.

HFI symptoms usually appear in infants when fruit, juices or sweetened preparations are introduced, and sometimes earlier because fructose is added to some formulas. They include vomiting, abdominal pain, lethargy, seizures, hypoglycaemia, jaundice, an enlarged liver and failure to thrive. Children and adults often avoid sweets and fruit themselves, having a natural aversion to these foods. Untreated disease can lead to liver and kidney failure, whereas when recognised and treated early, with consistent avoidance of fructose, sucrose and sorbitol, it has a good prognosis and allows a normal life and life expectancy (review by Singh and Sarma, 2022).

The hydrogen breath test is the most commonly used tool when fructose malabsorption is suspected. After preparation (set by the centre: usually an appropriate diet the day before and fasting), the patient drinks a fructose solution and then gives samples of exhaled air every 30 minutes, in which the concentration of hydrogen (and often methane) is measured. Hydrogen is produced solely by bacterial fermentation, so a rise in its concentration shows that part of the fructose reached bacteria instead of being absorbed. According to the North American Consensus (Rezaie et al., 2017), a positive result for carbohydrate malabsorption is a rise in hydrogen of at least 20 ppm over baseline, and recommended test doses include 25 g fructose and 25 g lactose.

The same consensus also recommends excluding SIBO before testing for carbohydrate malabsorption to avoid false-positive results: if bacteria colonise the small intestine, hydrogen appears early and independently of actual absorption. The European guideline (Hammer et al., 2022) goes further: breath tests for carbohydrate malabsorption require concurrent, validated symptom assessment before one can speak of intolerance. Exceeding 20 ppm without symptoms means malabsorption, not intolerance, and does not necessarily require treatment.

We must also be honest about limitations. In a study comparing two types of device (a handheld electrochemical one and a stationary gas chromatograph) in children (Hammer K et al., 2025), lactose tests showed 93.6% agreement, but fructose tests only 81.1%, with significant differences in results (49.1% positive on the stationary device vs 30.2% on the handheld one). The authors stress the need for caution when interpreting the fructose test. On top of that comes the question of dose: a large test dose (e.g. 50 g) produces a positive result in most healthy people, as noted above. The fructose test should therefore be done at the standard 25 g dose, in an experienced centre, and its result set against symptoms.

If symptoms are clearly linked to fructose and more serious causes have been excluded, the basis of management is diet, but in a sensible, time-limited form. Studies on pure fructose intolerance are few, whereas the effectiveness of the low-FODMAP diet, which includes restricting excess fructose, sorbitol and other fermentable carbohydrates, is well documented. In a network meta-analysis of 13 randomised trials (944 IBS patients; Black et al., 2022) the low-FODMAP diet ranked first among compared interventions: the risk of no improvement in overall symptoms was lower than with the habitual diet (RR 0.67; 95% CI 0.48-0.91). The authors note, however, that most trials were run in referral centres and did not study the reintroduction phase.

That last caveat is crucial. The restrictive elimination phase should not last indefinitely: the 2013 review noted that a diet restricting fructose and other fermentable carbohydrates controlled symptoms well but was associated with reduced bifidobacteria, which is a reason not to prolong restriction needlessly. A practical strategy has three phases: short elimination (usually a few weeks, under a dietitian's care), systematic reintroduction of individual groups and doses, and establishing an individual tolerance threshold, that is, the widest possible diet with acceptable symptoms. Details of the phased low-FODMAP diet are described in the knowledge base entry.

Small practical rules help and do not require giving up fruit: choose fruits with a more favourable glucose-to-fructose ratio or less sorbitol (e.g. a ripe banana in moderation, berries, citrus, kiwi) rather than apples, pears or mango in large portions; spread portions through the day; combine fruit with other components of a meal; avoid fruit juices and drinks sweetened with glucose-fructose syrup on an empty stomach; check labels for sorbitol (E420), xylitol and other polyols in 'sugar-free' products. Preparations containing xylose isomerase, which converts fructose to glucose, are being studied, but evidence for their real-world effectiveness is limited, so we do not regard them as standard.

Likewise, popular commercial 'food intolerance tests' from blood or hair, which have no confirmed diagnostic value, should be treated with scepticism: the 2023 narrative review stresses that the spread of unvalidated tests is one of the main causes of problematic management of patients with presumed food intolerances. Only the hydrogen breath test is used to assess fructose absorption, and genetic testing to diagnose HFI.

Fructose intolerance in the form of malabsorption is usually not dangerous, but digestive symptoms can also come from diseases that must not be missed. See a doctor if you have: unintentional weight loss, blood in or black stools, night-time diarrhoea or diarrhoea lasting longer than a few weeks, anaemia or iron deficiency, fever, severe abdominal pain, symptoms appearing for the first time after age 45-50, or a family history of colorectal cancer, inflammatory bowel disease or coeliac disease. In infants and small children, vomiting, drowsiness, seizures or jaundice after juice or fruit are a reason for immediate medical contact.

The most important thing to remember is to separate two concepts that are constantly mixed up online. Fructose malabsorption is a common feature of the gut and a matter of dose, not a verdict. Hereditary fructose intolerance is a rare metabolic disease that is not diagnosed with a trial diet or a breath test. Between them lies a large zone of sensible, practical management: a symptom diary, exclusion of serious causes, a test done at the right dose and cautiously interpreted, a short diet with a plan to return to a broad menu.